A genome‐wide analysis by Sung et al. identified TERT as the most common recurrent integration site, found in 23.7% of tumors, while Totoki et al. reported TERT integration in 22% of HBV‐positive HCC samples.64, 65. The gene discussed is TERT; the disease is hepatocellular carcinoma.